Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer

Journal of the National Cancer Institute

Volumn 104, Issue 19, 2012, Pages 1433-1457

  Theodoratou, Evropi ^a   Montazeri, Zahra ^b   Hawken, Steven ^c   Allum, Genevieve C D L ^d   Gong, Jacintha ^e   Tait, Valerie ^b   Kirac, Iva ^f   Tazari, Mahmood ^b   Farrington, Susan M ^g   Demarsh, Alex ^b,h   Zgaga, Lina ^a   Landry, Denise ^b   Benson, Helen E ^a   Read, Stephanie H ^a   Rudan, Igor ^a   Tenesa, Albert ^g   Dunlop, Malcolm G ^g   Campbell, Harry ^a   Little, Julian ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d MAIDSTONE HOSPITAL   (United Kingdom)

^e NINEWELLS HOSPITAL   (United Kingdom)

^f KBC Zagreb   (Croatia)

^g WESTERN GENERAL HOSPITAL   (United Kingdom)

^h PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLORECTAL CANCER; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PUBLICATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

BAYES THEOREM; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 20; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; COLORECTAL NEOPLASMS; DATA INTERPRETATION, STATISTICAL; DNA GLYCOSYLASES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SMAD7 PROTEIN;

EID: 84867315887     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs369     Document Type: Review

References (148)

1. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78-85. (Pubitemid 30451850)
2. Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet. 2009;10(6):353-358.
3. Zanke BW, Greenwood CM, Rangrej J, et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet. 2007;39(8):989-994. (Pubitemid 47185183)
4. Tomlinson I, Webb E, Carvajal-Carmona L, et al.; CORGI Consortium. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet. 2007;39(8): 984-988. (Pubitemid 47185182)
5. Tomlinson IP, Webb E, Carvajal-Carmona L, et al.; CORGI Consortium; EPICOLON Consortium. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet. 2008;40(5):623-630. (Pubitemid 351601204)
6. Tenesa A, Farrington SM, Prendergast JG, et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet. 2008;40(5):631-637. (Pubitemid 351601219)
7. Broderick P, Carvajal-Carmona L, Pittman AM, et al.; CORGI Consortium. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet. 2007;39(11):1315-1317. (Pubitemid 350034998)
8. Jaeger E, Webb E, Howarth K, et al.; CORGI Consortium. Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Genet. 2008;40(1):26-28.
9. Houlston RS, Webb E, Broderick P, et al.; Colorectal Cancer Association Study Consortium; CoRGI Consortium; International Colorectal Cancer Genetic Association Consortium. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet. 2008;40(12):1426-1435.
10. Houlston RS, Cheadle J, Dobbins SE, et al.; COGENT Consortium; CORGI Consortium; COIN Collaborative Group; COINB Collaborative Group. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet. 2010;42(11):973-977.
11. Ioannidis JP, Boffetta P, Little J, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37(1):120-132. (Pubitemid 351228620)
12. Khoury MJ, Bertram L, Boffetta P, et al. Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol. 2009;170(3):269-279.
13. Allen NC, Bagade S, McQueen MB, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008;40(7):827-834. (Pubitemid 351913655)
14. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007;39(1):17-23. (Pubitemid 46026496)
15. Chatzinasiou F, Lill CM, Kypreou K, et al. Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. J Natl Cancer Inst. 2011;103(16):1227-1235.
16. Campbell H, Rudan I. Interpretation of genetic association studies in complex disease. Pharmacogenomics J. 2002;2(6):349-360. (Pubitemid 36175797)
17. Yu W, Clyne M, Khoury MJ, Gwinn M. Phenopedia and Genopedia: disease-centered and gene-centered views of the evolving knowledge of human genetic associations. Bioinformatics. 2010;26(1):145-146.
18. -1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061-1073.
19. Theodoratou E, Kyle J, Cetnarskyj R, et al. Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(4): 684-693. (Pubitemid 46650569)
20. Cotterchio M, Manno M, Klar N, McLaughlin J, Gallinger S. Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry. Cancer Causes Control. 2005;16(7):865-875. (Pubitemid 41160050)
21. StataCorp. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP; 2009.
22. Ioannidis JP, Trikalinos TA. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ. 2007;176(8):1091-1096. (Pubitemid 46649731)
23. Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials. 1990;11(2):116-128. (Pubitemid 20136185)
24. Houlston RS, Ford D. Genetics of coeliac disease. QJM. 1996;89(10):737-743. (Pubitemid 26345113)
25. Cox A, Dunning AM, Garcia-Closas M, et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet. 2007;39(3): 352-358. (Pubitemid 46328496)
26. Wakefield J. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am J Hum Genet. 2007;81(2):208-227. (Pubitemid 47236070)
27. Pompanon F, Bonin A, Bellemain E, Taberlet P. Genotyping errors: causes, consequences and solutions. Nat Rev Genet. 2005;6(11):847-859.
28. Marchini J, Cardon LR, Phillips MS, Donnelly P. The effects of human population structure on large genetic association studies. Nat Genet. 2004;36(5):512-517. (Pubitemid 38620038)
29. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet. 2006;7(10):781-791. (Pubitemid 44413222)
30. Wacholder S, Rothman N, Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst. 2000;92(14):1151-1158.
31. Ioannidis JP, Ntzani EE, Trikalinos TA. 'Racial' differences in genetic effects for complex diseases. Nat Genet. 2004;36(12):1312-1318. (Pubitemid 39577941)
32. Thompson JR, Minelli C, Abrams KR, et al. Combining information from related meta-analyses of genetic association studies. Appl Statist. 2008;57:103-115.
33. Schully SD, Yu W, McCallum V, et al. Cancer GAMAdb: database of cancer genetic associations from meta-analyses and genome-wide association studies. Eur J Hum Genet. 2011;19(8):928-930.
34. Tuupanen S, Niittym?i I, Nousiainen K, et al. Allelic imbalance at rs6983267 suggests selection of the risk allele in somatic colorectal tumor evolution. Cancer Res. 2008;68(1):14-17. (Pubitemid 351380099)
35. Tuupanen S, Turunen M, Lehtonen R, et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet. 2009;41(8):885-890.
36. Park SL, Chang SC, Cai L, et al. Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3193-3202.
37. Wokolorczyk D, Gliniewicz B, Sikorski A, et al. A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res. 2008;68(23):9982-9986.
38. Yeager M, Orr N, Hayes RB, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet. 2007;39(5):645-649. (Pubitemid 46676108)
39. Thomas G, Jacobs KB, Yeager M, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet. 2008;40(3):310-315. (Pubitemid 351311773)
40. Eeles RA, Kote-Jarai Z, Giles GG, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008;40(3):316-321. (Pubitemid 351311772)
41. Pomerantz MM, Ahmadiyeh N, Jia L, et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet. 2009;41(8):882-884.
42. Cicek MS, Slager SL, Achenbach SJ, et al. Functional and clinical significance of variants localized to 8q24 in colon cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(9):2492-2500.
43. Prokunina-Olsson L, Hall JL. No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue. Mol Cancer. 2009;8:96.
44. Wright JB, Brown SJ, Cole MD. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol Cell Biol. 2010;30(6):1411-1420.
45. Verzi MP, Hatzis P, Sulahian R, et al. TCF4 and CDX2, major transcription factors for intestinal function, converge on the same cis-regulatory regions. Proc Natl Acad Sci USA. 2010;107(34):15157-15162.
46. Sotelo J, Esposito D, Duhagon MA, et al. Long-range enhancers on 8q24 regulate c-Myc. Proc Natl Acad Sci USA. 2010;107(7):3001-3005.
47. Loh YH, Mitrou PN, Wood A, et al. SMAD7 and MGMT genotype variants and cancer incidence in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study. Cancer Epidemiol. 2011;35(4):369-374.
48. Theodoratou E, Campbell H, Tenesa A, et al. A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer. 2010;103(12):1875-1884.
49. Shi M, Caprau D, Romitti P, Christensen K, Murray JC. Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genes MTHFR, MTHFD, MTRR, RFC1, and GCP2. Birth Defects Res Part A Clin Mol Teratol. 2003;67(8):545-549. (Pubitemid 37247668)
50. Mao R, Fan Y, Chen F, Sun D, Bai J, Fu S. Methylenetetrahydrofolate reductase gene polymorphisms in 13 Chinese ethnic populations. Cell Biochem Funct. 2008;26(3):352-358. (Pubitemid 351613177)
51. Houlston RS, Tomlinson IP. Polymorphisms and colorectal tumor risk. Gastroenterology. 2001;121(2):282-301. (Pubitemid 32729376)
52. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol. 2004;159(5):423-443. (Pubitemid 38280289)
53. Huang Y, Han S, Li Y, Mao Y, Xie Y. Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis. J Hum Genet. 2007;52(1):73-85. (Pubitemid 46020567)
54. Hubner RA, Houlston RS. MTHFR C677T and colorectal cancer risk: A meta-analysis of 25 populations. Int J Cancer. 2007;120(5):1027-1035. (Pubitemid 46214302)
55. Taioli E, Garza MA, Ahn YO , et al. Meta-and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Am J Epidemiol. 2009;170(10):1207-1221.
56. Zacho J, Yazdanyar S, Bojesen SE, Tybjg-Hansen A, Nordestgaard BG. Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controls. Int J Cancer. 2011;128(3):644-652.
57. Tanaka T, Scheet P, Giusti B, et al. Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am J Hum Genet. 2009;84(4):477-482.
58. Hazra A, Kraft P, Lazarus R, et al. Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum Mol Genet. 2009;18(23):4677-4687.
59. Par G, Chasman DI, Parker AN, et al. Novel associations of CPS1, MUT, NOX4, and DPEP1 with plasma homocysteine in a healthy population: a genome-wide evaluation of 13 974 participants in the Women's Genome Health Study. Circ Cardiovasc Genet. 2009;2(2):142-150.
60. Lange LA, Croteau-Chonka DC, Marvelle AF, et al. Genome-wide association study of homocysteine levels in Filipinos provides evidence for CPS1 in women and a stronger MTHFR effect in young adults. Hum Mol Genet. 2010;19(10):2050- 2058.
61. Khoury MJ, Little J, Gwinn M, Ioannidis JP. On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. Int J Epidemiol. 2007;36(2):439-445. (Pubitemid 47062866)
62. Niittym?i I, Tuupanen S, Li Y, et al. Systematic search for enhancer elements and somatic allelic imbalance at seven low-penetrance colorectal cancer predisposition loci. BMC Med Genet. 2011;12:23.
63. Wang GY, Lu CQ, Zhang RM, Hu XH, Luo ZW. The E-cadherin gene polymorphism 160C->A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies. Am J Epidemiol. 2008;167(1):7-14.
64. McColgan P, Sharma P. Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects. Int J Cancer. 2009;125(6):1473-1478.
65. Peng B, Cao L, Wang W, et al. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies. Mutagenesis. 2010;25(1):41-48.
66. Wang J, Wang H, Chen Y, Hao P, Zhang Y. Alcohol ingestion and colorectal neoplasia: a meta-analysis based on a Mendelian randomization approach. Colorectal Dis. 2011;13(5):e71-e78.
67. Takeshita T, Morimoto K, Yamaguchi N, et al. Relationships between cigarette smoking, alcohol drinking, the ALDH2 genotype and adenomatous types of colorectal polyps in male self-defense force officials. J Epidemiol. 2000;10(6):366-371.
68. Hirose M, Kono S, Tabata S, et al. Genetic polymorphisms of methylenetetrahydrofolate reductase and aldehyde dehydrogenase 2, alcohol use and risk of colorectal adenomas: Self-Defense Forces Health Study. Cancer Sci. 2005;96(8):513-518. (Pubitemid 41387304)
69. Jiang Z, Li C, Xu Y, Cai S. A meta-analysis on XRCC1 and XRCC3 polymorphisms and colorectal cancer risk. Int J Colorectal Dis. 2010;25(2):169-180.
70. Wang B, Wang D, Huang G, Zhang C, Xu DH, Zhou W. XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. Int J Colorectal Dis. 2010;25(3):313-321.
71. Naccarati A, Pardini B, Hemminki K, Vodicka P. Sporadic colorectal cancer and individual susceptibility: a review of the association studies investigating the role of DNA repair genetic polymorphisms. Mutat Res. 2007;635(2-3):118-145. (Pubitemid 46756400)
72. Tian Y, Li Y, Hu Z, Wang D, Sun X, Ren C. Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis. Int J Colorectal Dis. 2010;25(2):161-168.
73. Tan XL, Nieters A, Kropp S, Hoffmeister M, Brenner H, Chang-Claude J. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and metaanalysis. Int J Cancer. 2008;122(11):2573-2580. (Pubitemid 351590492)
74. Lewis RC, Bostick RM, Xie D, et al. Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas. Cancer Res. 2003;63(23):8549-8553. (Pubitemid 37549515)
75. Schernhammer ES, Tranah GJ, Giovannucci E, et al. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br J Cancer. 2006;94(6):928-934.
76. Fang F, Yu L, Zhong Y, Yao L. TGFB1 509 C/T polymorphism and colorectal cancer risk: a meta-analysis. Med Oncol. 2010;27(4):1324-1328.
77. Kaklamani VG, Hou N, Bian Y, et al. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies. J Clin Oncol. 2003;21(17): 3236-3243. (Pubitemid 46606255)
78. Skoglund J, Song B, Dal? J, et al. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk. Clin Cancer Res. 2007;13(12):3748-3752. (Pubitemid 46955140)
79. Liao RY , Mao C, Qiu LX, Ding H, Chen Q, Pan HF. TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls. Mol Biol Rep. 2010;37(7):3227-3232.
80. Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD. Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res. 2002;62(12):3361-3364. (Pubitemid 34651378)
81. Hubner RA, Liu JF, Sellick GS, Logan RF, Houlston RS, Muir KR. Thymidylate synthase polymorphisms, folate and B-vitamin intake, and risk of colorectal adenoma. Br J Cancer. 2007;97(10):1449-1456. (Pubitemid 350114796)
82. Hubner RA, Muir KR, Liu JF, et al. Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence. Cancer Epidemiol Biomarkers Prev. 2006;15(9):1607-1613. (Pubitemid 44497094)
83. Little J, Sharp L, Masson LF, et al. Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in the Grampian region of Scotland. Int J Cancer. 2006;119(9):2155-2164. (Pubitemid 44423675)
84. McKay JA, Murray GI, Weaver RJ, Ewen SW, Melvin WT, Burke MD. Xenobiotic metabolising enzyme expression in colonic neoplasia. Gut. 1993;34(9):1234-1239. (Pubitemid 23274547)
85. Mercurio MG, Shiff SJ, Galbraith RA, Sassa S. Expression of cytochrome P450 mRNAs in the colon and the rectum in normal human subjects. Biochem Biophys Res Commun. 1995;210(2):350-355.
86. Lampen A, Bader A, Bestmann T, Winkler M, Witte L, Borlak JT. Catalytic activities, protein-and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines. Xenobiotica. 1998;28(5):429-441. (Pubitemid 28238255)
87. Jin JQ, Hu YY, Niu YM, et al. CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis. World J Gastroenterol. 2011;17(2):260-266.
88. Chen K, Jiang QT, He HQ. Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol. 2005;11(3):331-335. (Pubitemid 40125233)
89. Smits KM, Gaspari L, Weijenberg MP, et al. Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC study. Biomarkers. 2003;8(3-4):299-310. (Pubitemid 37184384)
90. Ye Z, Parry JM. A meta-analysis of 20 case-control studies of the glutathione S-transferase M1 (GSTM1) status and colorectal cancer risk. Med Sci Monit. 2003;9(10):SR83-SR91. (Pubitemid 37309310)
91. He HQ, Chen K, Zhang Y, Tong F, Fan CH, Song L. Glutathione S-transferase M1 polymorphism and the risk on colorectal cancer: a multilevel meta regression. Zhonghua Liu Xing Bing Xue Za Zhi. 2005;26(12):992-994.
92. Economopoulos KP, Sergentanis TN. GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis. Eur J Cancer. 2010;46(9):1617-1631.
93. Gao Y, Cao Y, Tan A, Liao C, Mo Z, Gao F. Glutathione S-transferase M1 polymorphism and sporadic colorectal cancer risk: An updating metaanalysis and HuGE review of 36 case-control studies. Ann Epidemiol. 2010;20(2):108-121.
94. Raimondi S, Botteri E, Iodice S, Lowenfels AB, Maisonneuve P. Genesmoking interaction on colorectal adenoma and cancer risk: review and meta-analysis. Mutat Res. 2009;670(1-2):6-14.
95. Liao C, Cao Y, Wu L, Huang J, Gao F. An updating meta-analysis of the glutathione S-transferase T1 polymorphisms and colorectal cancer risk: a HuGE review. Int J Colorectal Dis. 2010;25(1):25-37.
96. Wan H, Zhou Y, Yang P, Chen B, Jia G, Wu X. Genetic polymorphism of glutathione S-transferase T1 and the risk of colorectal cancer: a metaanalysis. Cancer Epidemiol. 2010;34(1):66-72.
97. Ingles SA, Wang J, Coetzee GA, Lee ER, Frankl HD, Haile RW. Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States). Cancer Causes Control. 2001;12(7):607-614. (Pubitemid 32758592)
98. Kim HS, Newcomb PA, Ulrich CM, et al. Vitamin D receptor polymorphism and the risk of colorectal adenomas: evidence of interaction with dietary vitamin D and calcium. Cancer Epidemiol Biomarkers Prev. 2001;10(8):869-874. (Pubitemid 32738599)
99. Boyapati SM, Bostick RM, McGlynn KA, et al. Calcium, vitamin D, and risk for colorectal adenoma: dependency on vitamin D receptor BsmI polymorphism and nonsteroidal anti-inflammatory drug use? Cancer Epidemiol Biomarkers Prev. 2003;12(7):631-637. (Pubitemid 36899843)
100. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge MJ, Houlston RS; Members of UKCAP Consortium. Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence. Int J Cancer. 2008;123(3):586-593. (Pubitemid 351898416)
101. Egan JB, Thompson PA, Ashbeck EL, et al. Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. Cancer Res. 2010;70(4):1496-1504.
102. Kocarnik JD, Hutter CM, Slattery ML, et al. Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19(12):3131-3139.
103. Slattery ML, Samowitz W, Ballard L, Schaffer D, Leppert M, Potter JD. A molecular variant of the APC gene at codon 1822: its association with diet, lifestyle, and risk of colon cancer. Cancer Res. 2001;61(3):1000-1004. (Pubitemid 32174417)
104. Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hunter DJ. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma. Cancer Epidemiol Biomarkers Prev. 2005;14(4):863-870. (Pubitemid 40478549)
105. Wong HL, Peters U, Hayes RB, et al. Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. Eur J Cancer. 2010;46(13):2457-2466.
106. Xu W, Li Y, Wang X, et al. PPARgamma polymorphisms and cancer risk: a meta-analysis involving 32,138 subjects. Oncol Rep. 2010;24(2):579-585.
107. Lu YL, Li GL, Huang HL, Zhong J, Dai LC. Peroxisome proliferatoractivated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis. World J Gastroenterol. 2010;16(17):2170-2175.
108. Brockton N, Little J, Sharp L, Cotton SC. N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol. 2000;151(9):846-861. (Pubitemid 30461126)
109. Ye Z, Parry JM. Meta-analysis of 20 case-control studies on the N-acetyltransferase 2 acetylation status and colorectal cancer risk. Med Sci Monit. 2002;8(8):CR558-CR565. (Pubitemid 34959945)
110. Yu K, Zhang J, Zhang J, et al. Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis. Eur J Hum Genet. 2010;18(3):370-378.
111. Gao Y, Pan X, Su T, Mo Z, Cao Y, Gao F. Glutathione S-transferase P1 Ile105Val polymorphism and colorectal cancer risk: a meta-analysis and HuGE review. Eur J Cancer. 2009;45(18):3303-3314.
112. Moore LE, Huang WY, Chatterjee N, et al. GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1823-1827. (Pubitemid 40995101)
113. Tijhuis MJ, Wark PA, Aarts JM, et al. GSTP1 and GSTA1 polymorphisms interact with cruciferous vegetable intake in colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2005;14(12):2943-2951. (Pubitemid 43068829)
114. Skjelbred CF, Saeb?M, Hjart?er A, et al. Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas. BMC Cancer. 2007;7:228.
115. Northwood EL, Elliott F, Forman D, et al. Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk. Pharmacogenet Genomics. 2010;20(5):315-326.
116. Chen X, Guan J, Song Y, et al. IGF-I (CA) repeat polymorphisms and risk of cancer: a meta-analysis. J Hum Genet. 2008;53(3):227-238.
117. Chen W, Wang S, Tian T, et al. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies. Eur J Hum Genet. 2009;17(12):1668-1675.
118. Dahabreh IJ, Linardou H, Bouzika P, Varvarigou V, Murray S. TP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19(7):1840-1847.
119. Economopoulos KP, Sergentanis TN, Zagouri F, Zografos GC. Association between p53 Arg72Pro polymorphism and colorectal cancer risk: a metaanalysis. Onkologie. 2010;33(12):666-674.
120. Tang NP, Wu YM, Wang B, Ma J. Systematic review and meta-analysis of the association between P53 codon 72 polymorphism and colorectal cancer. Eur J Surg Oncol. 2010;36(5):431-438.
121. Wang JJ, Zheng Y, Sun L, et al. TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis. Mol Biol Rep. 2011;38(8): 4847-4853.
122. Rozek LS, Rennert G, Gruber SB. APC E1317Q is not associated with Colorectal Cancer in a population-based case-control study in Northern Israel. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2325-2327. (Pubitemid 44877066)
123. Cao H, Xu Z, Long H, Li XQ, Li SL. The-765C allele of the cyclooxygenase-2 gene as a potential risk factor of colorectal cancer: a meta-analysis. Tohoku J Exp Med. 2010;222(1):15-21.
124. Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N. Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1126-1131.
125. Siezen CL, Bueno-de-Mesquita HB, Peeters PH, Kram NR, van Doeselaar M, van Kranen HJ. Polymorphisms in the genes involved in the arachidonic acid-pathway, fish consumption and the risk of colorectal cancer. Int J Cancer. 2006;119(2):297-303.
126. Ueda N, Maehara Y, Tajima O, Tabata S, Wakabayashi K, Kono S. Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study. Cancer Sci. 2008;99(3):576-581. (Pubitemid 351228576)
127. Gong Z, Bostick RM, Xie D, et al. Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma. Int J Colorectal Dis. 2009;24(6):647-654.
128. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge MJ, Houlston RS; Members of the UKCAP Consortium. Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial. Int J Cancer. 2007;121(9):2001-2004. (Pubitemid 47463163)
129. Barry EL, Sansbury LB, Grau MV, et al. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence-data from a randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2009;18(10):2726-2733.
130. Chao C, Zhang ZF, Berthiller J, Boffetta P, Hashibe M. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(5):979-987. (Pubitemid 43823527)
131. Liu L, Liu L, Zeng F, et al. Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-control studies. J Cancer Res Clin Oncol. 2011;137(6):1027-1036.
132. Fan W, Maoqing W, Wangyang C, et al. Relationship between the polymorphism of tumor necrosis factor-a-308 G>A and susceptibility to inflammatory bowel diseases and colorectal cancer: a meta-analysis. Eur J Hum Genet. 2011;19(4):432-437.
133. Zhou GW, Hu J, Li Q. CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis. World J Gastroenterol. 2010;16(23):2949-2953.
134. Hawken SJ, Greenwood CM, Hudson TJ, et al. The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer. Hum Genet. 2010;128(1):89-101.
135. Frazer KA, Murray SS, Schork NJ, Topol EJ. Human genetic variation and its contribution to complex traits. Nat Rev Genet. 2009;10(4):241-251.
136. Butler WJ, Ryan P, Roberts-Thomson IC. Metabolic genotypes and risk for colorectal cancer increased risk in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Gastroenterology. 1997;112:A542.
137. Zhong Y, Huang Y, Huang Y, et al. Effects of O6-methylguanine-DNA methyltransferase (MGMT) polymorphisms on cancer: a meta-analysis. Mutagenesis. 2010;25(1):83-95.
138. Tenesa A, Campbell H, Barnetson R, Porteous M, Dunlop M, Farrington SM. Association of MUTYH and colorectal cancer. Br J Cancer. 2006;95(2):239-242. (Pubitemid 44050924)
139. Lubbe SJ, Di Bernardo MC, Chandler IP, Houlston RS. Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol. 2009;27(24):3975-3980.
140. Avezz A, Agostini M, Pucciarelli S, et al. The role of MYH gene in genetic predisposition to colorectal cancer: another piece of the puzzle. Cancer Lett. 2008;268(2):308-313.
141. Balaguer F, Castellv Bel S, Castells A, et al. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, populationbased study. Clin Gastroenterol Hepatol. 2007;5(3):379-387. (Pubitemid 46420561)
142. Pereira C, Medeiros RM, Dinis-Ribeiro MJ. Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available? Eur J
143. Ewart-Toland A, Dai Q, Gao YT, et al. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis. 2005;26(8):1368-1373. (Pubitemid 41417879)
144. Hu Z, Li X, Qu X, et al. Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis. Carcinogenesis. 2010;31(4):643-647.
145. Fang F, Yu XJ, Yu L, Yao L. MDM2 309 T/G polymorphism is associated with colorectal cancer risk especially in Asians: a meta-analysis. Med Oncol. 2011;28(4):981-985.
146. Wilkening S, Bermejo JL, Hemminki K. MDM2 SNP309 and cancer risk: a combined analysis. Carcinogenesis. 2007;28(11):2262-2267. (Pubitemid 350119563)
147. Theodoratou E, Farrington SM, Tenesa A, et al. Modification of the inverse association between dietary vitamin D intake and colorectal cancer risk by a FokI variant supports a chemoprotective action of Vitamin D intake mediated through VDR binding. Int J Cancer. 2008;123(9):2170-2179.
148. Hutter CM, Slattery ML, Duggan DJ, et al. Characterization of the association between 8q24 and colon cancer: gene-environment exploration and meta-analysis. BMC Cancer. 2010;10:670.